Sei Investments Co. Lowers Stock Position in Tenet Healthcare Corporation $THC

Sei Investments Co. lessened its position in Tenet Healthcare Corporation (NYSE:THC) by 16.7% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 283,520 shares of the company’s stock after selling 56,902 shares during the quarter. Sei Investments Co.’s holdings in Tenet Healthcare were worth $53,502,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in THC. Triumph Capital Management purchased a new position in shares of Tenet Healthcare during the third quarter worth about $25,000. Activest Wealth Management purchased a new position in Tenet Healthcare in the 4th quarter valued at $26,000. Elyxium Wealth LLC purchased a new position in Tenet Healthcare during the fourth quarter worth about $29,000. Meeder Asset Management Inc. lifted its holdings in shares of Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after buying an additional 114 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the second quarter valued at $35,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Analyst Ratings Changes

THC has been the subject of a number of research analyst reports. TD Cowen dropped their target price on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Royal Bank Of Canada lowered their price target on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a report on Friday, May 1st. Morgan Stanley set a $254.00 price objective on Tenet Healthcare in a report on Friday, May 1st. Barclays boosted their target price on Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Stephens cut their price target on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. Seventeen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $246.47.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet beat Q2 expectations by a wide margin, reporting $6.12 EPS versus estimates around $4.26, while revenue of $6.04 billion also came in above forecasts. The company cited strong same-store revenue growth and effective expense management. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Management raised FY 2026 EPS guidance to $20.30-$21.69, well above prior Street expectations, signaling that the earnings beat may not be a one-quarter event. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Investor enthusiasm was further supported by commentary highlighting hospital growth, expense control, and M&A momentum, with multiple reports describing the quarter as a “blockbuster” and noting the stock’s strong response. Tenet’s Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade
• Neutral Sentiment: Tenet’s earnings call transcript and presentation may provide more detail on the quarter and outlook, but the main stock driver today appears to be the earnings beat and guidance increase rather than any new strategic surprise. Tenet Healthcare Corporation (THC) Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Media coverage also noted broader strength in hospital stocks, which may be adding to the move in Tenet Healthcare (THC). Why Tenet Healthcare Stock Is Soaring Today

Insider Transactions at Tenet Healthcare

In related news, Director J Robert Kerrey sold 5,638 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This trade represents a 10.79% decrease in their position. The SEC filing for this sale provides additional information. 0.97% of the stock is currently owned by corporate insiders.

Tenet Healthcare Price Performance

THC stock opened at $233.10 on Friday. The stock’s 50 day moving average price is $185.16 and its 200 day moving average price is $197.62. The firm has a market cap of $20.08 billion, a P/E ratio of 8.99, a PEG ratio of 1.93 and a beta of 1.27. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Friday, July 24th. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 27.17% and a net margin of 10.27%.The company had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same period in the previous year, the firm posted $4.02 earnings per share. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts expect that Tenet Healthcare Corporation will post 21 earnings per share for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.